Dupilimab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Asthma by Body Mass Index

被引:5
|
作者
Korn, Stephanie [1 ]
Busse, William W. [2 ]
Maria Echave-Sustaeta, Jose [3 ]
Dixon, Anne E. [4 ]
Mucsi, Janos [5 ]
Rice, Megan S. [6 ]
Deniz, Yamo [7 ]
Rowe, Paul [8 ]
Staudinger, Heribert W. [8 ]
Amin, Nikhil [7 ]
Ruddy, Marcella [7 ]
Graham, Neil M. H. [7 ]
Teper, Ariel [8 ]
机构
[1] Johannes Gutenberg Univ Mainz KdoR, Univ Med, Mainz, Germany
[2] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA
[3] Hosp Univ Quironsalud Madrid, Madrid, Spain
[4] Univ Vermont, Burlington, VT 05405 USA
[5] Erzsebet Gondozohaz, Godollo, Hungary
[6] Sanofi, Cambridge, MA USA
[7] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[8] Sanofi, Bridgewater, MA USA
关键词
Asthma; -; management;
D O I
10.1183/13993003.congress-2019.PA2753
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
PA2753
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Tezepelumab administration in moderate-to-severe uncontrolled asthma: Is it all about eosinophils?
    Puzzovio, Pier Giorgio
    Eliashar, Ron
    Levi-Schaffer, Francesca
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (05) : 1582 - 1584
  • [42] Type 2 Biomarkers Associated with Dupilumab Efficacy in Patients with Uncontrolled, Moderate-To-Severe Asthma Enrolled in the Phase 3 Study LIBERTY ASTHMA QUEST
    Wenzel, S. E.
    Pavord, I.
    Zhang, B.
    Maroni, J.
    Rowe, P.
    Hamilton, J. D.
    Swanson, B. N.
    Amin, N.
    Pirozzi, G.
    Graham, N. M.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [43] Dupilumab Induces Clinical Remission in Patients With Uncontrolled, Moderate-to-Severe, Type 2 Inflammatory Asthma
    Pavord, I. D.
    Israel, E.
    Szefler, S. J.
    Brusselle, G.
    Rabe, K. F.
    Chen, Z.
    Altincatal, A.
    Radwan, A.
    Pandit-Abid, N.
    Amin, N.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y. M.
    Khan, A.
    Lederer, D. J.
    Zhang, Y.
    Busse, W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [44] HIGH SYSTEMIC CORTICOSTEROID BURDEN AMONG PATIENTS WITH UNCONTROLLED MODERATE-TO-SEVERE ASTHMA IN THE UNITED STATES
    Song, Xue
    Chen, Chao
    Soliman, Mena
    Wang, Zhixiao
    Cheng, Wei-Han
    Asmus, Michael J.
    Kwah, Jason
    Ramratnam, Sima
    Lugogo, Njira L.
    CHEST, 2024, 166 (04) : 4712A - 4714A
  • [45] Effect of Dupilumab in Korean Patients With Uncontrolled Moderate-to-Severe Asthma: A LIBERTY ASTHMA QUEST Sub-analysis
    Rhee, Chin Kook
    Park, Jung-Won
    Park, Heung-Woo
    Cho, You Sook
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2022, 14 (02) : 182 - 195
  • [46] Dupilumab Treatment Leads to Clinical Asthma Remission in Patients With Uncontrolled Moderate-to-Severe Asthma With Type 2 Inflammation
    Pavord, Ian
    Busse, William
    Israel, Elliot
    Szefler, Stanley
    Chen, Zhen
    Daizadeh, Nadia
    Lederer, David
    Mannent, Leda
    Amin, Nikhil
    Laws, Elizabeth
    Ruddy, Marcella
    Rowe, Paul
    Deniz, Yamo
    Khan, Asif
    Zhang, Yi
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB4 - AB4
  • [47] Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma
    Corren, Jonathan
    Mansfield, Lyndon E.
    Pertseva, Tetyana
    Blahzko, Viktor
    Kaiser, Kirsten
    RESPIRATORY MEDICINE, 2013, 107 (02) : 180 - 195
  • [48] Efficacy of omalizumab in cat-allergic patients with moderate-to-severe persistent asthma
    Massanari, Marc
    Kianifard, Farid
    Zeldin, Robert K.
    Geba, Gregory P.
    ALLERGY AND ASTHMA PROCEEDINGS, 2009, 30 (05) : 534 - 539
  • [49] A Randomized, Controlled Phase 3 Study, LIBERTY ASTHMA QUEST, Evaluating the Efficacy and Safety of Dupilumab in Uncontrolled Moderate-to-Severe Asthma
    Castro, M.
    Corren, J.
    Pavord, I. D.
    Maspero, J. F.
    Wenzel, S. E.
    Rabe, K. F.
    Busse, W. W.
    Ford, L. B.
    Sher, L.
    FitzGerald, J.
    Katelaris, C.
    Tohda, Y.
    Zhang, B.
    Staudinger, H.
    Pirozzi, G.
    Amin, N.
    Ruddy, M.
    Akinlade, B.
    Khan, A.
    Chao, J.
    Martincova, R.
    Graham, N. M.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [50] Effect of exacerbation history on clinical response to dupilumab in moderate-to-severe uncontrolled asthma
    Corren, Jonathan
    Katelaris, Constance H.
    Castro, Mario
    Maspero, Jorge F.
    Ford, Linda B.
    Halpin, David M. G.
    Rice, Megan S.
    Radwan, Amr
    Deniz, Yamo
    Rowe, Paul J.
    Teper, Ariel
    Djandji, Michel
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58 (04)